CAI logo

CAI
Caris Life Sciences Inc.

907
Mkt Cap
$5.41B
Volume
3.33M
52W High
$42.50
52W Low
$16.28
PE Ratio
-9.99
CAI Fundamentals
Price
$19.84
Prev Close
$19.13
Open
$19.13
50D MA
$19.11
Beta
0.91
Avg. Volume
1.75M
EPS (Annual)
-$1.90
P/B
9.36
Rev/Employee
$439,887.87
$7,250.15
Loading...
Loading...
News
all
press releases
Caris Life Sciences Reports First Quarter 2026 Financial Results
Caris Life Sciences Reports First Quarter 2026 Financial Results Caris Life Sciences Reports First Quarter 2026 Financial Results PR Newswire IRVING, Texas, May 7, 2026 Revenue growth of 79% driven...
PR Newswire·1h ago
News Placeholder
More News
News Placeholder
UBS Group AG Raises Stock Position in Caris Life Sciences, Inc. $CAI
UBS Group AG lifted its stake in shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) by 825.9% during the fourth quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·1d ago
News Placeholder
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis
Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant...
PR Newswire·2d ago
News Placeholder
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies Caris Life Sciences Receives MolDX Approval for Caris...
PR Newswire·3d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Downgraded by Wall Street Zen to Hold
Wall Street Zen lowered Caris Life Sciences from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·6d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Shares Gap Down - Here's What Happened
Caris Life Sciences (NASDAQ:CAI) Shares Gap Down - Time to Sell...
MarketBeat·6d ago
News Placeholder
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients
Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide Benefit in Glioblastoma Patients Caris Life Sciences Publishes Study Validating Caris AI Insights for Temozolomide...
PR Newswire·8d ago
News Placeholder
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Average Rating of "Hold" from Brokerages
Shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Get Free Report) have received a consensus recommendation of "Hold" from the seven ratings firms that are currently covering the stock, MarketBeat...
MarketBeat·12d ago
News Placeholder
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference
Caris Life Sciences to Present at the BofA Securities 2026 Health Care Conference and the Goldman Sachs 47th Annual Global Healthcare Conference Caris Life Sciences to Present at the BofA Securities...
PR Newswire·13d ago
News Placeholder
146,100 Shares in Caris Life Sciences, Inc. $CAI Bought by DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale bought a new stake in Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·14d ago
<
1
2
...
>

Latest CAI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.